Experimental coronavirus treatment leronlimab shows 'very promising' response in some COVID-19 patients

[perugu_vada]

https://www.foxnews.com/science/experimental-coronavirus-treatment-leronlimab-very-promising-response-in-some-covid-19-patients
 

Leronlimab is a viral-entry inhibitor that targets HIV and breast cancer.

In a statement released Monday CytoDyn gave an update on over 30 patients COVID-19 patients recently treated with leronlimab in more than 4 hospitals and clinics across the U.S.  Patients have received leronlimab as part of Emergency Investigational New Drug (EINDs) treatments authorized by the FDA and two CytoDyn clinical trials.

“More than 25 patients have been administered leronlimab under EINDs authorized by the U.S. Food and Drug Administration (FDA),” the biotech explained. “Rate of response in mild-to-moderate patients under EIND has been very promising with the first five patients treated being removed from oxygen.”

“We are planning to rapidly enroll 75 patients and report the results to the FDA as quickly as possible.”